The global market for Non-Invasive Blood Glucose Monitoring System was estimated to be worth US$ 20 million in 2023 and is forecast to a readjusted size of US$ 83 million by 2030 with a CAGR of 8.5% during the forecast period 2024-2030

Non-Invasive Blood Glucose Monitoring System - Market

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-Invasive Blood Glucose Monitoring System, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Non-Invasive Blood Glucose Monitoring System by region & country, by Type, and by Application.

The Non-Invasive Blood Glucose Monitoring System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Blood Glucose Monitoring System.

Market Segmentation

Scope of Non-Invasive Blood Glucose Monitoring System - Market Report

Report Metric	Details
Report Name	Non-Invasive Blood Glucose Monitoring System - Market
Forecasted market size in 2030	US$ 83 million
CAGR	8.5%
Forecasted years	2024 - 2030
Segment by Type:	Wearable Blood Glucose Monitoring Systems Non-wearable /Table-top Blood Glucose Monitoring Systems
Segment by Application	Hospitals Homecare Clinics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, Medtronic plc, F. Hoffmann-La Roche Ltd., Ascensia Diabetes Care, Dexcom, Inc., Sanofi Novo Nordisk, Insulet Corporation, Ypsomed Holdings, Glysens Incorporated
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Non-Invasive Blood Glucose Monitoring System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Non-Invasive Blood Glucose Monitoring System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Non-Invasive Blood Glucose Monitoring System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Non-Invasive Blood Glucose Monitoring System - Market size in 2030?

Ans: The Non-Invasive Blood Glucose Monitoring System - Market size in 2030 will be US$ 83 million.

Who are the main players in the Non-Invasive Blood Glucose Monitoring System - Market report?

Ans: The main players in the Non-Invasive Blood Glucose Monitoring System - Market are Abbott Laboratories, Medtronic plc, F. Hoffmann-La Roche Ltd., Ascensia Diabetes Care, Dexcom, Inc., Sanofi Novo Nordisk, Insulet Corporation, Ypsomed Holdings, Glysens Incorporated

What are the Application segmentation covered in the Non-Invasive Blood Glucose Monitoring System - Market report?

Ans: The Applications covered in the Non-Invasive Blood Glucose Monitoring System - Market report are Hospitals, Homecare, Clinics

What are the Type segmentation covered in the Non-Invasive Blood Glucose Monitoring System - Market report?

Ans: The Types covered in the Non-Invasive Blood Glucose Monitoring System - Market report are Wearable Blood Glucose Monitoring Systems, Non-wearable /Table-top Blood Glucose Monitoring Systems

1 Market Overview

1.1 Non-Invasive Blood Glucose Monitoring System Product Introduction

1.2 Global Non-Invasive Blood Glucose Monitoring System Market Size Forecast

1.2.1 Global Non-Invasive Blood Glucose Monitoring System Sales Value (2019-2030)

1.2.2 Global Non-Invasive Blood Glucose Monitoring System Sales Volume (2019-2030)

1.2.3 Global Non-Invasive Blood Glucose Monitoring System Sales Price (2019-2030)

1.3 Non-Invasive Blood Glucose Monitoring System Market Trends & Drivers

1.3.1 Non-Invasive Blood Glucose Monitoring System Industry Trends

1.3.2 Non-Invasive Blood Glucose Monitoring System Market Drivers & Opportunity

1.3.3 Non-Invasive Blood Glucose Monitoring System Market Challenges

1.3.4 Non-Invasive Blood Glucose Monitoring System Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Non-Invasive Blood Glucose Monitoring System Players Revenue Ranking (2023)

2.2 Global Non-Invasive Blood Glucose Monitoring System Revenue by Company (2019-2024)

2.3 Global Non-Invasive Blood Glucose Monitoring System Players Sales Volume Ranking (2023)

2.4 Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Company Players (2019-2024)

2.5 Global Non-Invasive Blood Glucose Monitoring System Average Price by Company (2019-2024)

2.6 Key Manufacturers Non-Invasive Blood Glucose Monitoring System Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Non-Invasive Blood Glucose Monitoring System Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Non-Invasive Blood Glucose Monitoring System

2.9 Non-Invasive Blood Glucose Monitoring System Market Competitive Analysis

2.9.1 Non-Invasive Blood Glucose Monitoring System Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Non-Invasive Blood Glucose Monitoring System Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Blood Glucose Monitoring System as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Wearable Blood Glucose Monitoring Systems

3.1.2 Non-wearable /Table-top Blood Glucose Monitoring Systems

3.2 Global Non-Invasive Blood Glucose Monitoring System Sales Value by Type

3.2.1 Global Non-Invasive Blood Glucose Monitoring System Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Non-Invasive Blood Glucose Monitoring System Sales Value, by Type (2019-2030)

3.2.3 Global Non-Invasive Blood Glucose Monitoring System Sales Value, by Type (%) (2019-2030)

3.3 Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Type

3.3.1 Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Non-Invasive Blood Glucose Monitoring System Sales Volume, by Type (2019-2030)

3.3.3 Global Non-Invasive Blood Glucose Monitoring System Sales Volume, by Type (%) (2019-2030)

3.4 Global Non-Invasive Blood Glucose Monitoring System Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Homecare

4.1.3 Clinics

4.2 Global Non-Invasive Blood Glucose Monitoring System Sales Value by Application

4.2.1 Global Non-Invasive Blood Glucose Monitoring System Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Non-Invasive Blood Glucose Monitoring System Sales Value, by Application (2019-2030)

4.2.3 Global Non-Invasive Blood Glucose Monitoring System Sales Value, by Application (%) (2019-2030)

4.3 Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Application

4.3.1 Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Non-Invasive Blood Glucose Monitoring System Sales Volume, by Application (2019-2030)

4.3.3 Global Non-Invasive Blood Glucose Monitoring System Sales Volume, by Application (%) (2019-2030)

4.4 Global Non-Invasive Blood Glucose Monitoring System Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Non-Invasive Blood Glucose Monitoring System Sales Value by Region

5.1.1 Global Non-Invasive Blood Glucose Monitoring System Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Non-Invasive Blood Glucose Monitoring System Sales Value by Region (2019-2024)

5.1.3 Global Non-Invasive Blood Glucose Monitoring System Sales Value by Region (2025-2030)

5.1.4 Global Non-Invasive Blood Glucose Monitoring System Sales Value by Region (%), (2019-2030)

5.2 Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Region

5.2.1 Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Region (2019-2024)

5.2.3 Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Region (2025-2030)

5.2.4 Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Region (%), (2019-2030)

5.3 Global Non-Invasive Blood Glucose Monitoring System Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Non-Invasive Blood Glucose Monitoring System Sales Value, 2019-2030

5.4.2 North America Non-Invasive Blood Glucose Monitoring System Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Non-Invasive Blood Glucose Monitoring System Sales Value, 2019-2030

5.5.2 Europe Non-Invasive Blood Glucose Monitoring System Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Non-Invasive Blood Glucose Monitoring System Sales Value, 2019-2030

5.6.2 Asia Pacific Non-Invasive Blood Glucose Monitoring System Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Non-Invasive Blood Glucose Monitoring System Sales Value, 2019-2030

5.7.2 South America Non-Invasive Blood Glucose Monitoring System Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Non-Invasive Blood Glucose Monitoring System Sales Value, 2019-2030

5.8.2 Middle East & Africa Non-Invasive Blood Glucose Monitoring System Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Non-Invasive Blood Glucose Monitoring System Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Non-Invasive Blood Glucose Monitoring System Sales Value

6.2.1 Key Countries/Regions Non-Invasive Blood Glucose Monitoring System Sales Value, 2019-2030

6.2.2 Key Countries/Regions Non-Invasive Blood Glucose Monitoring System Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Non-Invasive Blood Glucose Monitoring System Sales Value, 2019-2030

6.3.2 United States Non-Invasive Blood Glucose Monitoring System Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Non-Invasive Blood Glucose Monitoring System Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Non-Invasive Blood Glucose Monitoring System Sales Value, 2019-2030

6.4.2 Europe Non-Invasive Blood Glucose Monitoring System Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Non-Invasive Blood Glucose Monitoring System Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Non-Invasive Blood Glucose Monitoring System Sales Value, 2019-2030

6.5.2 China Non-Invasive Blood Glucose Monitoring System Sales Value by Type (%), 2023 VS 2030

6.5.3 China Non-Invasive Blood Glucose Monitoring System Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Non-Invasive Blood Glucose Monitoring System Sales Value, 2019-2030

6.6.2 Japan Non-Invasive Blood Glucose Monitoring System Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Non-Invasive Blood Glucose Monitoring System Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Non-Invasive Blood Glucose Monitoring System Sales Value, 2019-2030

6.7.2 South Korea Non-Invasive Blood Glucose Monitoring System Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Non-Invasive Blood Glucose Monitoring System Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Non-Invasive Blood Glucose Monitoring System Sales Value, 2019-2030

6.8.2 Southeast Asia Non-Invasive Blood Glucose Monitoring System Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Non-Invasive Blood Glucose Monitoring System Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Non-Invasive Blood Glucose Monitoring System Sales Value, 2019-2030

6.9.2 India Non-Invasive Blood Glucose Monitoring System Sales Value by Type (%), 2023 VS 2030

6.9.3 India Non-Invasive Blood Glucose Monitoring System Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Abbott Laboratories

7.1.1 Abbott Laboratories Company Information

7.1.2 Abbott Laboratories Introduction and Business Overview

7.1.3 Abbott Laboratories Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Abbott Laboratories Non-Invasive Blood Glucose Monitoring System Product Offerings

7.1.5 Abbott Laboratories Recent Development

7.2 Medtronic plc

7.2.1 Medtronic plc Company Information

7.2.2 Medtronic plc Introduction and Business Overview

7.2.3 Medtronic plc Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Medtronic plc Non-Invasive Blood Glucose Monitoring System Product Offerings

7.2.5 Medtronic plc Recent Development

7.3 F. Hoffmann-La Roche Ltd.

7.3.1 F. Hoffmann-La Roche Ltd. Company Information

7.3.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview

7.3.3 F. Hoffmann-La Roche Ltd. Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2019-2024)

7.3.4 F. Hoffmann-La Roche Ltd. Non-Invasive Blood Glucose Monitoring System Product Offerings

7.3.5 F. Hoffmann-La Roche Ltd. Recent Development

7.4 Ascensia Diabetes Care

7.4.1 Ascensia Diabetes Care Company Information

7.4.2 Ascensia Diabetes Care Introduction and Business Overview

7.4.3 Ascensia Diabetes Care Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Ascensia Diabetes Care Non-Invasive Blood Glucose Monitoring System Product Offerings

7.4.5 Ascensia Diabetes Care Recent Development

7.5 Dexcom, Inc.

7.5.1 Dexcom, Inc. Company Information

7.5.2 Dexcom, Inc. Introduction and Business Overview

7.5.3 Dexcom, Inc. Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Dexcom, Inc. Non-Invasive Blood Glucose Monitoring System Product Offerings

7.5.5 Dexcom, Inc. Recent Development

7.6 Sanofi Novo Nordisk

7.6.1 Sanofi Novo Nordisk Company Information

7.6.2 Sanofi Novo Nordisk Introduction and Business Overview

7.6.3 Sanofi Novo Nordisk Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Sanofi Novo Nordisk Non-Invasive Blood Glucose Monitoring System Product Offerings

7.6.5 Sanofi Novo Nordisk Recent Development

7.7 Insulet Corporation

7.7.1 Insulet Corporation Company Information

7.7.2 Insulet Corporation Introduction and Business Overview

7.7.3 Insulet Corporation Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Insulet Corporation Non-Invasive Blood Glucose Monitoring System Product Offerings

7.7.5 Insulet Corporation Recent Development

7.8 Ypsomed Holdings

7.8.1 Ypsomed Holdings Company Information

7.8.2 Ypsomed Holdings Introduction and Business Overview

7.8.3 Ypsomed Holdings Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Ypsomed Holdings Non-Invasive Blood Glucose Monitoring System Product Offerings

7.8.5 Ypsomed Holdings Recent Development

7.9 Glysens Incorporated

7.9.1 Glysens Incorporated Company Information

7.9.2 Glysens Incorporated Introduction and Business Overview

7.9.3 Glysens Incorporated Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Glysens Incorporated Non-Invasive Blood Glucose Monitoring System Product Offerings

7.9.5 Glysens Incorporated Recent Development

8 Industry Chain Analysis

8.1 Non-Invasive Blood Glucose Monitoring System Industrial Chain

8.2 Non-Invasive Blood Glucose Monitoring System Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Non-Invasive Blood Glucose Monitoring System Sales Model

8.5.2 Sales Channel

8.5.3 Non-Invasive Blood Glucose Monitoring System Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Medtronic Inc

F Hoffmann La Roche Ltd

Ascensia Diabetes Care

List of Tables

Table 1. Non-Invasive Blood Glucose Monitoring System Market Trends

Table 2. Non-Invasive Blood Glucose Monitoring System Market Drivers & Opportunity

Table 3. Non-Invasive Blood Glucose Monitoring System Market Challenges

Table 4. Non-Invasive Blood Glucose Monitoring System Market Restraints

Table 5. Global Non-Invasive Blood Glucose Monitoring System Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Non-Invasive Blood Glucose Monitoring System Revenue Market Share by Company (2019-2024)

Table 7. Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Non-Invasive Blood Glucose Monitoring System Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Non-Invasive Blood Glucose Monitoring System Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Non-Invasive Blood Glucose Monitoring System Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Non-Invasive Blood Glucose Monitoring System Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Non-Invasive Blood Glucose Monitoring System

Table 13. Global Non-Invasive Blood Glucose Monitoring System Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Blood Glucose Monitoring System as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Non-Invasive Blood Glucose Monitoring System Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Non-Invasive Blood Glucose Monitoring System Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Non-Invasive Blood Glucose Monitoring System Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Non-Invasive Blood Glucose Monitoring System Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Non-Invasive Blood Glucose Monitoring System Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Non-Invasive Blood Glucose Monitoring System Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Non-Invasive Blood Glucose Monitoring System Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Non-Invasive Blood Glucose Monitoring System Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Non-Invasive Blood Glucose Monitoring System Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Non-Invasive Blood Glucose Monitoring System Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Non-Invasive Blood Glucose Monitoring System Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Non-Invasive Blood Glucose Monitoring System Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Non-Invasive Blood Glucose Monitoring System Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Non-Invasive Blood Glucose Monitoring System Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Non-Invasive Blood Glucose Monitoring System Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Non-Invasive Blood Glucose Monitoring System Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Non-Invasive Blood Glucose Monitoring System Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Non-Invasive Blood Glucose Monitoring System Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Non-Invasive Blood Glucose Monitoring System Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Non-Invasive Blood Glucose Monitoring System Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Non-Invasive Blood Glucose Monitoring System Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Non-Invasive Blood Glucose Monitoring System Sales Value by Region (2019-2024) & (%)

Table 44. Global Non-Invasive Blood Glucose Monitoring System Sales Value by Region (2025-2030) & (%)

Table 45. Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Region (2019-2024) & (%)

Table 49. Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Region (2025-2030) & (%)

Table 50. Global Non-Invasive Blood Glucose Monitoring System Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Non-Invasive Blood Glucose Monitoring System Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Non-Invasive Blood Glucose Monitoring System Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Non-Invasive Blood Glucose Monitoring System Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Non-Invasive Blood Glucose Monitoring System Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Non-Invasive Blood Glucose Monitoring System Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Non-Invasive Blood Glucose Monitoring System Sales Volume, (2025-2030) & (K Units)

Table 57. Abbott Laboratories Company Information

Table 58. Abbott Laboratories Introduction and Business Overview

Table 59. Abbott Laboratories Non-Invasive Blood Glucose Monitoring System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Abbott Laboratories Non-Invasive Blood Glucose Monitoring System Product Offerings

Table 61. Abbott Laboratories Recent Development

Table 62. Medtronic plc Company Information

Table 63. Medtronic plc Introduction and Business Overview

Table 64. Medtronic plc Non-Invasive Blood Glucose Monitoring System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Medtronic plc Non-Invasive Blood Glucose Monitoring System Product Offerings

Table 66. Medtronic plc Recent Development

Table 67. F. Hoffmann-La Roche Ltd. Company Information

Table 68. F. Hoffmann-La Roche Ltd. Introduction and Business Overview

Table 69. F. Hoffmann-La Roche Ltd. Non-Invasive Blood Glucose Monitoring System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. F. Hoffmann-La Roche Ltd. Non-Invasive Blood Glucose Monitoring System Product Offerings

Table 71. F. Hoffmann-La Roche Ltd. Recent Development

Table 72. Ascensia Diabetes Care Company Information

Table 73. Ascensia Diabetes Care Introduction and Business Overview

Table 74. Ascensia Diabetes Care Non-Invasive Blood Glucose Monitoring System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Ascensia Diabetes Care Non-Invasive Blood Glucose Monitoring System Product Offerings

Table 76. Ascensia Diabetes Care Recent Development

Table 77. Dexcom, Inc. Company Information

Table 78. Dexcom, Inc. Introduction and Business Overview

Table 79. Dexcom, Inc. Non-Invasive Blood Glucose Monitoring System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Dexcom, Inc. Non-Invasive Blood Glucose Monitoring System Product Offerings

Table 81. Dexcom, Inc. Recent Development

Table 82. Sanofi Novo Nordisk Company Information

Table 83. Sanofi Novo Nordisk Introduction and Business Overview

Table 84. Sanofi Novo Nordisk Non-Invasive Blood Glucose Monitoring System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Sanofi Novo Nordisk Non-Invasive Blood Glucose Monitoring System Product Offerings

Table 86. Sanofi Novo Nordisk Recent Development

Table 87. Insulet Corporation Company Information

Table 88. Insulet Corporation Introduction and Business Overview

Table 89. Insulet Corporation Non-Invasive Blood Glucose Monitoring System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Insulet Corporation Non-Invasive Blood Glucose Monitoring System Product Offerings

Table 91. Insulet Corporation Recent Development

Table 92. Ypsomed Holdings Company Information

Table 93. Ypsomed Holdings Introduction and Business Overview

Table 94. Ypsomed Holdings Non-Invasive Blood Glucose Monitoring System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Ypsomed Holdings Non-Invasive Blood Glucose Monitoring System Product Offerings

Table 96. Ypsomed Holdings Recent Development

Table 97. Glysens Incorporated Company Information

Table 98. Glysens Incorporated Introduction and Business Overview

Table 99. Glysens Incorporated Non-Invasive Blood Glucose Monitoring System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Glysens Incorporated Non-Invasive Blood Glucose Monitoring System Product Offerings

Table 101. Glysens Incorporated Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Non-Invasive Blood Glucose Monitoring System Downstream Customers

Table 105. Non-Invasive Blood Glucose Monitoring System Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Non-Invasive Blood Glucose Monitoring System Product Picture

Figure 2. Global Non-Invasive Blood Glucose Monitoring System Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Non-Invasive Blood Glucose Monitoring System Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Non-Invasive Blood Glucose Monitoring System Sales Volume (2019-2030) & (K Units)

Figure 5. Global Non-Invasive Blood Glucose Monitoring System Sales Price (2019-2030) & (US$/Unit)

Figure 6. Non-Invasive Blood Glucose Monitoring System Report Years Considered

Figure 7. Global Non-Invasive Blood Glucose Monitoring System Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Non-Invasive Blood Glucose Monitoring System Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-Invasive Blood Glucose Monitoring System Revenue in 2023

Figure 10. Non-Invasive Blood Glucose Monitoring System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Wearable Blood Glucose Monitoring Systems Picture

Figure 12. Non-wearable /Table-top Blood Glucose Monitoring Systems Picture

Figure 13. Global Non-Invasive Blood Glucose Monitoring System Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Non-Invasive Blood Glucose Monitoring System Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Non-Invasive Blood Glucose Monitoring System Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Non-Invasive Blood Glucose Monitoring System Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Hospitals

Figure 19. Product Picture of Homecare

Figure 20. Product Picture of Clinics

Figure 21. Global Non-Invasive Blood Glucose Monitoring System Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Non-Invasive Blood Glucose Monitoring System Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Non-Invasive Blood Glucose Monitoring System Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Non-Invasive Blood Glucose Monitoring System Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Non-Invasive Blood Glucose Monitoring System Price by Application (2019-2030) & (US$/Unit)

Figure 26. North America Non-Invasive Blood Glucose Monitoring System Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Non-Invasive Blood Glucose Monitoring System Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Non-Invasive Blood Glucose Monitoring System Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Non-Invasive Blood Glucose Monitoring System Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Non-Invasive Blood Glucose Monitoring System Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Non-Invasive Blood Glucose Monitoring System Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Non-Invasive Blood Glucose Monitoring System Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Non-Invasive Blood Glucose Monitoring System Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Non-Invasive Blood Glucose Monitoring System Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Non-Invasive Blood Glucose Monitoring System Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Non-Invasive Blood Glucose Monitoring System Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Non-Invasive Blood Glucose Monitoring System Sales Volume (%), (2019-2030)

Figure 38. United States Non-Invasive Blood Glucose Monitoring System Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Non-Invasive Blood Glucose Monitoring System Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Non-Invasive Blood Glucose Monitoring System Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Non-Invasive Blood Glucose Monitoring System Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Non-Invasive Blood Glucose Monitoring System Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Non-Invasive Blood Glucose Monitoring System Sales Value by Application (%), 2023 VS 2030

Figure 44. China Non-Invasive Blood Glucose Monitoring System Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Non-Invasive Blood Glucose Monitoring System Sales Value by Type (%), 2023 VS 2030

Figure 46. China Non-Invasive Blood Glucose Monitoring System Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Non-Invasive Blood Glucose Monitoring System Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Non-Invasive Blood Glucose Monitoring System Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Non-Invasive Blood Glucose Monitoring System Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Non-Invasive Blood Glucose Monitoring System Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Non-Invasive Blood Glucose Monitoring System Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Non-Invasive Blood Glucose Monitoring System Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Non-Invasive Blood Glucose Monitoring System Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Non-Invasive Blood Glucose Monitoring System Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Non-Invasive Blood Glucose Monitoring System Sales Value by Application (%), 2023 VS 2030

Figure 56. India Non-Invasive Blood Glucose Monitoring System Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Non-Invasive Blood Glucose Monitoring System Sales Value by Type (%), 2023 VS 2030

Figure 58. India Non-Invasive Blood Glucose Monitoring System Sales Value by Application (%), 2023 VS 2030

Figure 59. Non-Invasive Blood Glucose Monitoring System Industrial Chain

Figure 60. Non-Invasive Blood Glucose Monitoring System Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions